Prestige Consumer Healthcare (PBH) Non-Current Deferred Tax Liability (2016 - 2025)
Prestige Consumer Healthcare has reported Non-Current Deferred Tax Liability over the past 15 years, most recently at $449.3 million for Q4 2025.
- For Q4 2025, Non-Current Deferred Tax Liability rose 8.72% year-over-year to $449.3 million; the TTM value through Dec 2025 reached $449.3 million, up 8.72%, while the annual FY2025 figure was $419.6 million, 3.96% up from the prior year.
- Non-Current Deferred Tax Liability for Q4 2025 was $449.3 million at Prestige Consumer Healthcare, up from $444.9 million in the prior quarter.
- Over five years, Non-Current Deferred Tax Liability peaked at $484.8 million in Q1 2022 and troughed at $384.0 million in Q2 2023.
- A 5-year average of $429.9 million and a median of $433.2 million in 2021 define the central range for Non-Current Deferred Tax Liability.
- Biggest five-year swings in Non-Current Deferred Tax Liability: rose 16.19% in 2021 and later decreased 13.24% in 2023.
- Year by year, Non-Current Deferred Tax Liability stood at $444.8 million in 2021, then increased by 2.48% to $455.8 million in 2022, then decreased by 12.87% to $397.1 million in 2023, then increased by 4.06% to $413.3 million in 2024, then rose by 8.72% to $449.3 million in 2025.
- Business Quant data shows Non-Current Deferred Tax Liability for PBH at $449.3 million in Q4 2025, $444.9 million in Q3 2025, and $426.9 million in Q2 2025.